Unlock instant, AI-driven research and patent intelligence for your innovation.

Macroencapsulated secretory cells

一种胶原分泌、细胞的技术,应用在细胞胶囊化、微型胶囊、胶囊输送等方向,能够解决膜功能疑问等问题

Inactive Publication Date: 2002-07-17
THE ROGOSIN INST
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this experiment has not been extensively redone, so its function as a membrane for human islet transplantation remains in doubt

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Macroencapsulated secretory cells
  • Macroencapsulated secretory cells
  • Macroencapsulated secretory cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1 Isolation of pancreatic islets

[0046] Islets were isolated from rats using a modification of the method described by Gotoh, et. al. Transplantation 40:437 (1985).

[0047] Collagen solution (XI type collagenase, Sigma Chemical, St.Louis, MO, 1mg / ml, containing 2mg / ml Sigma V type bovine serum albumin and 1mg / ml CaCl 2 ) into the pancreas via the common bile canaliculus (Gotoh et al, Transplantation 40:437 (1985)). Remove the pancreas and collect in a flask on ice. Once the pancreases from the 4 rats have been collected, place the flasks in a 38°C water bath for 30 minutes. The resulting digested tissue was washed 4 times with cold (8°C) HBSS (Hank's Balanced Salt Solution).

[0048] Undigested tissue, large lymph nodes, and other extraneous matter are removed by repeated flow through the tissue with removal of the supernatant. Purified islets were separated under a discontinuous Ficoll gradient consisting of 25%, 23%, 21% and 11% Ficoll layers prepared i...

Embodiment 2

[0052] A Preparation of agarose-coated agarose-collagen islet macrobeads

[0053] The 1000 islets obtained by the method of Example 1 were washed 4 times in RPMI complete medium with fetal bovine serum removed. The islets were then added to a test tube containing 50 µl of 1% atelocollagen solution in phosphate buffered saline to suspend the islets. 100 μl of 1% low-viscosity agarose (SigmaType XII) prepared in RPMI or MEN (Minimal Essential Medium) maintained at 60°C was added to the collagen-islet suspension, and the contents of the tube were immediately separated as individual Large drops were transferred onto sterile mineral oil or Teflon sheets kept at room temperature. After 1 minute, the drops turned into semi-solid beads, which were then transferred to RPMI antibiotic medium at 37°C, and the beads were washed 3 times with the same medium to remove all oil. Finally, rinse twice with complete medium (37°C) in a humidified medium containing 5% CO at 37°C 2 Incubate over...

Embodiment 3

[0061] Example 3 Transplantation of islet beads into mice

[0062] A Recipient and donor rats

[0063] The mice used were male C57BL / 6 and BALB / c species, and recipient mice were rendered diabetic with a single intravenous injection of streptozotocin (170-200 mg / kg).

[0064] Non-fasting plasma glucose levels were measured prior to induction of diabetes and blood glucose levels were monitored in all recipient mice by tail vein blood samples using an ExacTech Pen Senson, only those mice with serum glucose levels > 400 mg / dl on the day of transplantation were used.

[0065] Wistar Furth rats were used as xenograft donors.

[0066] B Xenotransplantation of large islet beads into the peritoneal cavity

[0067] At the time of xenotransplantation, gently place the islet beads obtained in Example 2 (A), (B), and (C) into respective plates containing RPMI antibiotic medium, and replace the culture medium to remove all serum proteins. Base 3 times, diabetic recipient mice were anest...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to macroencapsulation of secretory cells in a hydrophilic gel material, therapeutic methods employing the macroencapsulated secretory cells, and preserving the secretory cells by macroencapsulation.

Description

field of invention [0001] The present invention relates to macroencapsulation of secretory cells in a hydrophilic gel material, a method of treatment using the macroencapsulated secretory cells and a method of preserving secretory cells by macroencapsulation. technical background [0002] Secretory cells are cells characterized as secreting active substances such as, but not limited to, hormones (eg, insulin), growth hormones, cytokines, and the like. Its role in biological processes is well understood and need not be stated here. Many diseases and pathological conditions are related to insufficient normal function of secretory cells, such as insufficient secretion of products, such as hypothyroidism and cretinism are caused by lack of thyroxine, pituitary dwarfism is due to lack of growth hormone secreted by the pituitary gland; Lesch -Hyhan's syndrome is due to hypoxanthine-guanine phosphoribosyltransferase deficiency; acute liver failure is due to hepatic nutrient defici...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/16A61K9/50A61K35/12A61K35/28A61K35/39A61K38/00A61K47/26A61K47/36A61P3/10C12N5/00C12N5/07C12N5/071C12N11/04C12N11/10
CPCA61K2035/126A61K9/1658C12N5/0012A61K35/39C12N11/04A61K38/00C12N2533/76A61K9/1652A61K9/5036C12N5/0677C12N2533/54A61P5/00A61P3/10A61K47/26
Inventor 坎蒂·基恩艾伯特·L·罗宾
Owner THE ROGOSIN INST